Skip to main content

mHealth Device Market Assessment Brief 2019 Development by Clinical Areas till - 2025

mHealth Device Market is Witnessing Rising Acceptance of Connected Technology Solutions;
mHealth refers to mobile health, one of the most disruptive trends ever occurred in the healthcare sector. It is a public health practice supported by mobile devices, commonly used for health services, information, and data collection through mobile communication devices, such as mobile phones, computers, tablets or PDAs, and wearable devices like smartwatches. mHealth is also defined as a sub-segment of eHealth, which uses ICT (information & communication technology), such as communications satellites, patient monitors, etc.
the global mHealth device market share is expected to create a valuation of over USD 48,663.2 MN by 2023. In its mHealth market growth analysis, MRFR also asserts that the market would register a massive 35.03% CAGR throughout the forecast period (2017 – 2023).
Research Synopsis
MHealth devices include mobile devices, real-time monitors for vital signs, and telemedicine. mHealth solutions allow users to access the collected data to check and maintain the health-related activities, using technologies such as Bluetooth, mobile network (GSM/GPRS/3G/4G), and Wi-Fi. Such advantages are encouraging the acceptance of mHealth devices in growing numbers of healthcare facilities, which increases the size of the mHealth solutions market globally.
The rapid adoption of portable and smart devices such as tablets and smartphones is a key driving force for the growth of the connected healthcare device market services.Besides, advancements in connectivity and mHealth technology solutions act as a major tailwind for the market growth. Simultaneously, factors such as rising patient involvement n personal healthcare and the introduction of connected healthcare solutions are impacting the growth of the market positively. An increase in lifestyle disease and benefits of mHealth solutions such as cost-effectiveness & convenience foster market growth. Furthermore, raising awareness among patients is driving market growth.
Major Players
Agreement & partnership, mergers & acquisitions, and expansion are key strategies traced from the analysis of recent developments of key players.
Players leading the global mHealth device market include Apple Inc. (US), Allscripts (US), Athenahealth, Inc. (US), GE Healthcare (UK), Cerner (US), Medtronic (Ireland), and Koninklijke Philips NV (Netherlands), among others. 
Industry/Innovation/ Related News: 
  • January 18, 2019 —–Johnson & Johnson (US), a multinational healthcare products manufacturing company, announced its partnership with Apple Inc. (US), a technology giant for the ECG monitoring project to accelerate the diagnosis and improve health outcomes for AFib patients. For the project, partnering companies would see if Apple’s new iWatch with a built-in electrocardiogram (ECG)can be integrated with an app developed by the J&J.
Access the Premium Research Details along with Complete TOC: https://www.marketresearchfuture.com/reports/m-health-device-market-2866
Global MHealth Device Market – Segments 
MRFR has segmented the market into three dynamics to widen the scope of understanding,
By Type                            : Medical Devices, Health & Fitness Devices, and Other Devices (Mobile Telemedicine/Tele-Care Devices & Home Care Devices)
By Application                : Monitoring Applications, Diagnosis & Treatment, Education & Awareness, Healthcare Management, Wellness & Prevention, and others.
By Regions                       : Asia Pacific, North America, Europe, and the Rest-of-the-World.
This unique mHealth device can be used for earlier detection of atrial fibrillation (AFib), a heart condition causing irregular and often abnormally fast heart rate. The device and app’s impact on diagnosis would be assessed for adherence to AFib medication. Apple has FDA clearance for its latest iWatch for monitoring heart health.
Contact:
Akash Anand,
Market Research Future
Office No. 524/528, Amanora Chambers
Magarpatta Road, Hadapsar
Pune – 411028
Maharashtra, India
+1 646 845 9312
Labels:

Comments

Post a Comment

Popular posts from this blog

Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Growth Drivers, Restraints and Opportunities, Forecast To 2025

Global Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Size Research Report: Information by Treatment (Drug Class (Mitogen-Activated Protein Kinases (MAPK) Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors, Others), Oxygen Therapy, Lung Transplant, Others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2025 Global  Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Size  Insights 2020 provides a unique tool for evaluating the Market, highlighting opportunities, and supporting strategic and tactical decision-making. This report recognizes that in this rapidly-evolving and competitive environment, up-to-date Marketing information is essential to monitor performance and make critical decisions for growth and profitability. Some of the key players operating for the global market analysis are  Boehringer Ingelheim GMBH, Biogen, Novartis AG, Medicinova, Inc., Bristol-Myers Squibb Company, Galapagos NV, F. Hoffmann-La R...
3 comments
Read more

Krabbe Disease Treatment Market Set to Surge Significantly with New Innovations, Application, Recent Technology

  Krabbe Disease Treatment Market Overview Krabbe disease is an incurable medical condition where the protective coating of nerve cells around the brain are destroyed which causing nerve damage. The global Krabbe disease treatment market can reach a significant valuation, exhibiting a steady CAGR over the forecast period of 2016 to 2022, as per a research report published by Market Research Future (MRFR). The market has been growing continuously on account of increasing incidence of Krabbe disease across the globe. Classification of Krabbe disease under orphan disease has propelled the growth of the market. Pharmaceutical companies receive incentives to develop medicine for rare disease along with reduced fees in protocol assistance and protection from competition after the medicine is marketed. Increased government funding for drug development and easy approvals, tax credits on clinical research, reduction in the amount of registration fees also aid the growth of the market. These...
Post a Comment
Read more

Peptic Ulcer Drugs Market Rapid Development By Manufactures Business Growth Future

  Peptic Ulcer Drugs Market Scenario: Peptic ulcer drugs are used to treat erosion of the gastrointestinal lining due to a variety of factors. Peptic ulcer is the result of an imbalance between aggressive and defensive fluids in the stomach. Peptic ulcer includes gastric, esophageal and duodenal ulcer. The global peptic ulcer drugs market was valued at approximately $29 billion in 2015, and is expected to reach $36.27 billion by 2022. Thus, the market is expected to show an average growth at a CAGR of 3.8 % from 2016 to 2022. The major driving factors for petic ulcers drug market are stress, drug induced ulcers, growing rate of infection by H.Pyrroli, changes in food, rise in cancer, tobacco and alcohol use. Constraining factors of this market are patent expiry, comparatively good treatment regimen of proton pump inhibitors, resistance of H.Pyrolli, extreme market fragmentation into many companies and great penetration of generics. Avail a Free Sample@  https://www.market...
Post a Comment
Read more